Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

OBJECTIVE: The addition of bevacizumab to fluoropyrimidine-based combination chemotherapy as first-line therapy for metastatic colorectal cancer results in clinically significant improvements in patient outcome. However, clinical trials have been conducted primarily in Caucasian patients with only a...

Full description

Saved in:
Bibliographic Details
Main Authors: Doi, Toshihiko, Boku, Narikazu, Kato, Ken, Komatsu, Yoshito, Yamaguchi, Kensei, Muro, Kei, Hamamoto, Yasuo, Sato, Atsushi, Koizumi, Wasaburo, Mizunuma, Nobuyuki, Takiuchi, Hiroya
Format: Artigo
Language:Inglês
Published: Oxford University Press 2010
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947844/
https://ncbi.nlm.nih.gov/pubmed/20462981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyq069
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items